載入...
Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis
BACKGROUND: Fibulin-3 (FBLN3) was recently presented as a promising novel biomarker for malignant pleural mesothelioma (MPM), warranting independent validation studies. METHODS: ELISA was used to measure cellular and secreted FBLN3 in cell lines, in plasma of xenograft tumour-bearing mice, in plasma...
Na minha lista:
| 發表在: | Br J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4578085/ https://ncbi.nlm.nih.gov/pubmed/26263483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.286 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|